San Francisco confirmed that a child in the city became the first case of H5N1. A panel of biotech leaders discussed what ...

Cytosorbents ( (CTSO) ) has shared an update. CytoSorbents Corporation successfully closed an oversubscribed rights offering, raising $6.25 million in aggregate gross proceeds, which satisfies a debt ...

Corporation announced that the Company closed the subscription period of its previously announced rights offering at 5:00 PM ...

Oversubscribed Rights Offering Generated $6.25 Million in Aggregate Gross Proceeds Offering Proceeds Satisfies Debt Covenant, ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $8.71, a high ...

PRINCETON - CytoSorbents Corporation (NASDAQ:CTSO), a company specializing in blood purification therapies with a market capitalization of $51.21 million, today announced the establishment of a new ...

PRINCETON, N.J., Jan. 06, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...

PRINCETON, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...

(MENAFN- GlobeNewsWire - Nasdaq) PRINCETON, N.J., Jan. 06, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the ...